119 related articles for article (PubMed ID: 25560385)
21. Ingenol derivates promising for HIV eradication.
Poveda E
AIDS Rev; 2014; 16(4):246. PubMed ID: 25373349
[TBL] [Abstract][Full Text] [Related]
22. The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL; Marsili G; Battistini A; Sgarbanti M
Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
[TBL] [Abstract][Full Text] [Related]
23. The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.
Badia R; Grau J; Riveira-Muñoz E; Ballana E; Giannini G; Esté JA
Antiviral Res; 2015 Nov; 123():62-9. PubMed ID: 26348004
[TBL] [Abstract][Full Text] [Related]
24. Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation.
Vemula SV; Maxwell JW; Nefedov A; Wan BL; Steve J; Newhard W; Sanchez RI; Tellers D; Barnard RJ; Blair W; Hazuda D; Webber AL; Howell BJ
Antiviral Res; 2017 Mar; 139():161-170. PubMed ID: 27889530
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines.
Qu X; Ying H; Wang X; Kong C; Zhou X; Wang P; Zhu H
Curr HIV Res; 2013 Jan; 11(1):24-9. PubMed ID: 23092175
[TBL] [Abstract][Full Text] [Related]
26. Histone deactylase inhibitor SAHA induces a synergistic HIV-1 reactivation by 12-O-tetradecanoylphorbol-13-acetate in latently infected cells.
Park SY; Kim KC; Hong KJ; Kim SS; Choi BS
Intervirology; 2013; 56(4):242-8. PubMed ID: 23735807
[TBL] [Abstract][Full Text] [Related]
27. Abyssomicins G and H and atrop-abyssomicin C from the marine Verrucosispora strain AB-18-032.
Keller S; Nicholson G; Drahl C; Sorensen E; Fiedler HP; Süssmuth RD
J Antibiot (Tokyo); 2007 Jun; 60(6):391-4. PubMed ID: 17617698
[TBL] [Abstract][Full Text] [Related]
28. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
[TBL] [Abstract][Full Text] [Related]
29. Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetase.
Brown P; Eggleston DS; Haltiwanger RC; Jarvest RL; Mensah L; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Mar; 11(5):711-4. PubMed ID: 11266175
[TBL] [Abstract][Full Text] [Related]
30. Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.
Martínez-Bonet M; Clemente MI; Serramía MJ; Muñoz E; Moreno S; Muñoz-Fernández MÁ
Sci Rep; 2015 Nov; 5():16445. PubMed ID: 26563568
[TBL] [Abstract][Full Text] [Related]
31. HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.
Cohen J
Science; 2005 Aug; 309(5737):999-1000. PubMed ID: 16099956
[No Abstract] [Full Text] [Related]
32. A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137.
Zhang J; Li B; Qin Y; Karthik L; Zhu G; Hou C; Jiang L; Liu M; Ye X; Liu M; Hsiang T; Dai H; Zhang L; Liu X
Appl Microbiol Biotechnol; 2020 Feb; 104(4):1533-1543. PubMed ID: 31894364
[TBL] [Abstract][Full Text] [Related]
33. Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β.
Lai W; Huang L; Zhu L; Ferrari G; Chan C; Li W; Lee KH; Chen CH
J Med Chem; 2015 Nov; 58(21):8638-46. PubMed ID: 26509731
[TBL] [Abstract][Full Text] [Related]
34. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response.
Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I
FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221
[TBL] [Abstract][Full Text] [Related]
35. Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383.
Jarvest RL; Berge JM; Brown P; Hamprecht DW; McNair DJ; Mensah L; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Mar; 11(5):715-8. PubMed ID: 11266176
[TBL] [Abstract][Full Text] [Related]
36. Silent, but deadly--eliminating reservoirs of latent HIV.
Kay MS
Trends Biotechnol; 2003 Oct; 21(10):420-3. PubMed ID: 14512225
[No Abstract] [Full Text] [Related]
37. Total synthesis and biological evaluation of (-)-atrop-abyssomicin C.
Bihelovic F; Karadzic I; Matovic R; Saicic RN
Org Biomol Chem; 2013 Sep; 11(33):5413-24. PubMed ID: 23839049
[TBL] [Abstract][Full Text] [Related]
38. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
[TBL] [Abstract][Full Text] [Related]
39. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
40. Didehydro-Cortistatin A: a new player in HIV-therapy?
Mousseau G; Valente ST
Expert Rev Anti Infect Ther; 2016; 14(2):145-8. PubMed ID: 26581953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
